Projects approved for funding in 2016
| Code | Title | Organisation | Lead PI | Funding Amount | Abstract | Final Summary |
| TCS/16/06 | Antihypertensives as repurposed treatments for mood disorders: Scottish national linkage and UK Biobank investigation | University of Glasgow | Professor Daniel Smith | £250,897 | TCS/16/06 abstract | TSC/16/06 briefing |
| TCS/16/07 | The preclinical optimisation of targeted nanoparticles loaded with beta-emitting nuclides for molecular radiotherapy | University of Aberdeen | Dr Tim Andrew Davies Smith | £265,664 | TCS/16/07 abstract | TCS/16/07 Briefing |
| TCS/16/21 | Understanding barriers to participation in cancer trials amongst teenagers and young adults: qualitative study | NHS Lothian | Dr Angela Edgar | £130,367 | TCS/16/21 abstract | TCS/16/21 Briefing |
| TCS/16/24 | Accelerating clinical introduction of novel antibacterial drugs | University of Strathclyde | Dr Nicholas Tucker | £116,785 | TCS/16/24 abstract | TCS/16/24 Briefing |
| TCS/16/25 | Myocardial ischaemia in heart failure with preserved ejection fraction | University of Glasgow | Professor John JV McMurray | £299,650 | TCS/16/25 abstract | TCS/16/25 Briefing |
| TCS/16/31 | Cancer chemotherapeutics and the vasculature- endothelial effects of VEGF inhibitors in vivo in man | University of Glasgow | Dr Ninian N Lang | £86,594 | TCS/16/31 abstract | TCS/16/31 Briefing |
| TCS/16/37 | Exploiting hepatocyte and endothelial cell interactions for the development of scalable human liver tissue | University of Edinburgh | Dr David Hay | £297,868 | TCS/16/37 Abstract | TCS/16/37 Briefing |
| TCS/16/38 | Target radiotherapy of prostate cancer in combination with drugs exploiting the aberrant metabolism of tumours | University of Glasgow | Professor Rob Mairs | £295,710 | TCS/16/38 Abstract | Project active |
| TCS/16/47 | Long-term and high exposure effects of NB-UVB phototherapy in relation to increased risk of skin cancers: A 30 year retrospective cohort study in Scotland | University of Dundee | Dr Robert S Dawe | £128,404 | TCS/16/47 Abstract | TCS/16/47 Briefing |
| TCS/16/55 | Pain management and patient education for physical activity in intermittent claudiction (Prepaid): feasiblilty randomised controlled trial | University of Glasgow Caledonian | Dr Christopher Seenan | £244,085 | TCS/16/55 Abstract | TCS/16/55 Briefing |
| TCS/16/60 | Immunoglobulin replacement therapy for immunoglobulin S subclass 2 deficient patients with bronchiectasis | University of Edinburgh | Professor Adam Hill | £184,215 | TCS/16/60 Abstract | Project active |